Post hoc multiple comparisons showed a significantly higher intensity of Bmal1-IR in HCC mice than in PB controls in the late dark/activity phase (ZT20, p = 0.006) (Figure 4D,H,I). This evidence concerns the gene BMAL1 and hepatocellular carcinoma.